pgÓéÀÖ

Skip to main content

Contact pgÓéÀÖ

  

Contact Us

Want to do business with us

New Business Questions Inquiry Form

North American Base of Operations
515 Eastern Avenue
Allegan, Michigan 49010
+1 269 673 8451


Questions on product related concerns or complaints

Over the Counter Products
+1 800 719 9260
Contact Us

Infant Formula, Nutritional 
+1 800 272 5095
Contact Us

Ranir - a pgÓéÀÖ Oral Care Company
+1 866 532 6041 
Contact Us


On July 6, 2021, pgÓéÀÖ sold its former Rx Pharmaceuticals Business, which now operates independent of pgÓéÀÖ under the name of Padagis, LLC.

Contact Padagis
+1 800-775-2054

Find Padagis online:

Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding PRIALT® (ziconitide intrathecal infusion), please contact Jazz Pharmaceuticals at +1 888 774 2581.

Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding MAXIPIME® (cefepime hydrochloride, USP) for Injection or AZACTAM® (aztreonam for injection, USP), please contact Bristol Myers Squibb Medical Information (BMS) at +1 800 321 1335 or by email at Drug.Information@bms.com.

Corporate Headquarters

The Sharp Building
Hogan Place
Dublin 2, Ireland
+353 1 709 4000

Registered in Ireland
Registration Number 529592



Investor and Media Relations

Brad Joseph
Vice President Global Investor Relations
Global Investor Relations and Corporate Communications
Bradley.Joseph@perrigo.com
+1 269 686 3373

Nick Gallagher
Senior Manager Global Investor Relations
Global Investor Relations & Corporate Communications
Nicholas.Gallagher@perrigo.com
269-686-3238

Investor.Request@perrigo.com